Literature DB >> 8932679

The clay feet of bioequivalence testing.

G Levy1.   

Abstract

Mesh：

Year:  1995        PMID： 8932679     DOI： 10.1111/j.2042-7158.1995.tb03281.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  3 in total

1.  The Two Main Goals of Bioequivalence Studies.

Authors:  Laszlo Endrenyi; Henning H Blume; Laszlo Tothfalusi
Journal:  AAPS J       Date:  2017-02-02       Impact factor: 4.009

Review 2.  Metrics for the evaluation of bioequivalence of modified-release formulations.

Authors:  Laszlo Endrenyi; Laszlo Tothfalusi
Journal:  AAPS J       Date:  2012-08-22       Impact factor: 4.009

Review 3.  Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients.

Authors:  Atholl Johnston; Philip Belitsky; Ulrich Frei; John Horvath; Peter Hoyer; J Harold Helderman; Michael Oellerich; Stephen Pollard; Hany Riad; Paolo Rigotti; Paul Keown; Björn Nashan
Journal:  Eur J Clin Pharmacol       Date:  2004-06-17       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.